Resveratrol Dosage: Trial Amounts and the Red Wine Myth
Resveratrol is the compound behind the French paradox story, and that story has outlived most of the evidence that started it. The human trial literature is a much more sober read than the headlines were.
Human trials of resveratrol have used a wide range of daily amounts, commonly between 150 mg and 1,000 mg per day, with some studies going higher for short periods. A frequently cited crossover trial in obese men used 150 mg per day of a resveratrol formulation for 30 days and reported metabolic changes. Red wine contains only a few milligrams of resveratrol per litre, so no realistic amount of wine approaches trial doses. Resveratrol is poorly bioavailable and is rapidly metabolised, and gastrointestinal side effects become common at gram-scale doses.
Resveratrol amounts reported in the research literature
| Use case | Amount reported in sources | What to know |
|---|---|---|
| Metabolic outcomes in obese men | 150 mg per day for 30 days | Randomised double-blind crossover trial in Cell Metabolism reporting changes in metabolic markers. Source |
| General clinical trial range | Commonly 150–1,000 mg per day | Trials across cardiometabolic, cognitive and inflammatory endpoints have used a wide and inconsistent range. Source |
| Bioavailability | Very low; extensively metabolised after absorption | Human pharmacokinetic work shows resveratrol is absorbed but rapidly converted to sulfate and glucuronide metabolites. Source |
| Red wine as a source | Only a few milligrams per litre | Wine cannot deliver trial-scale amounts at any drinking volume that is remotely safe. Source |
Figures are amounts reported in the cited sources, not a personal recommendation. Your own amount depends on your health, medicines and blood work.
Where the red wine story came from and why it collapsed
The French paradox — comparatively low coronary heart disease alongside a rich diet — was attributed in the 1990s partly to red wine polyphenols, and resveratrol became the named suspect. Laboratory work showing resveratrol activating sirtuin enzymes and extending lifespan in yeast and simple organisms poured fuel on that.
Two things happened afterwards. The sirtuin activation mechanism turned out to be far more contested than the early papers implied, and the amounts producing effects in cell and animal work were vastly higher, relative to body weight, than anything wine could deliver.
Wine contains single-digit milligrams of resveratrol per litre. Reaching even the low end of the human trial range through wine would require volumes that would cause far more harm than any polyphenol could offset.
- Wine supplies a few milligrams of resveratrol per litre
- Trials use hundreds of milligrams per day
- Most supplement resveratrol comes from Japanese knotweed
- The sirtuin mechanism story is contested, not settled
What the human trials found
A 2011 randomised double-blind crossover trial published in Cell Metabolism gave 150 mg a day of a resveratrol formulation to obese men for 30 days and reported changes in metabolic rate, muscle mitochondrial function and several circulating markers, in a pattern the authors compared with caloric restriction.
Subsequent trials have been inconsistent. Studies in different populations — healthy adults, people with type 2 diabetes, older adults with cognitive complaints — have produced mixed results, and meta-analyses have generally reported small and heterogeneous effects.
The most reliable summary is that resveratrol has repeatedly produced measurable biochemical changes in small trials, and has not established a clinical benefit that holds up consistently across populations.
Bioavailability is the central practical problem
Human pharmacokinetic studies show that resveratrol is absorbed reasonably well but then almost entirely converted to sulfate and glucuronide metabolites, so very little unchanged resveratrol reaches circulation.
Whether those metabolites are inactive, or act as a reservoir that releases resveratrol in tissues, is an open research question rather than a solved one. This uncertainty sits underneath every dose recommendation in the category.
Formulations claiming enhanced absorption — micronised, liposomal, combined with piperine — address the pharmacokinetics without addressing whether more circulating resveratrol produces better outcomes.
Side effects concentrate at high doses
At the doses most supplements supply, resveratrol is generally well tolerated. At gram-scale doses, trials have reported nausea, diarrhoea, abdominal discomfort and flatulence often enough that these limit dose escalation.
Resveratrol also has weak oestrogenic activity in laboratory work, which is the basis for caution in hormone-sensitive conditions such as breast, ovarian or uterine cancer, endometriosis and uterine fibroids.
It inhibits platelet aggregation in vitro, so anticoagulant and antiplatelet users, and anyone approaching surgery, should raise it with a prescriber.
Drug interactions worth checking
Resveratrol inhibits several cytochrome P450 enzymes in laboratory studies, including CYP3A4, which handles a large share of prescription medicines. That makes clinically meaningful interactions plausible even though they are not well characterised in people.
The medicines where this matters most are the ones with narrow safety margins: anticoagulants, some immunosuppressants, certain antiarrhythmics and some statins.
The practical step is unglamorous but effective — show the bottle to a pharmacist and ask them to check it against your current list rather than assuming a plant extract is inert.
What the published studies found
Each entry below links straight to the paper or the health authority page so you can read the original rather than take our word for it.
- Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011.
Randomised, double-blind crossover trial
150 mg per day of resveratrol for 30 days was associated with changes in metabolic rate, muscle mitochondrial function and circulating metabolic markers in obese men.
- Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004.
Human pharmacokinetic study using labelled resveratrol
Resveratrol was well absorbed but underwent extensive metabolism to sulfate and glucuronide conjugates, leaving very low concentrations of the unchanged compound.
Side effects reported in the literature
Commonly reported
- Nausea
- Diarrhoea and abdominal discomfort at gram-scale doses
- Flatulence
Serious, seek medical advice
- Potential bleeding risk alongside anticoagulant or antiplatelet therapy
- Weak oestrogenic activity, relevant in hormone-sensitive conditions
- Possible interference with medicines metabolised by CYP3A4
Summarised from Cell Metabolism 2011 randomised crossover trial. Report anything unexpected to your own doctor or pharmacist.
Interactions to check with a pharmacist
| Medicine or condition | What sources report |
|---|---|
| Anticoagulants and antiplatelet medicines | Resveratrol inhibits platelet aggregation in laboratory work; additive risk is plausible. Source |
| Medicines metabolised by CYP3A4 | Enzyme inhibition in laboratory studies makes altered drug levels possible. Source |
| Hormone-sensitive conditions | Weak oestrogenic activity is the basis for specialist caution. Source |
This is not a complete interaction list. Check your own medicines with a pharmacist before combining anything.
This page is reference material, not medical advice. Supplements interact with prescription medicines and with each other. Talk to a doctor or pharmacist before starting anything, especially if you are pregnant, breastfeeding, managing a health condition or taking prescription medicine.
Frequently asked questions
How much resveratrol should I take?
Human trials have used a wide range, commonly 150 mg to 1,000 mg a day, and the frequently cited metabolic crossover trial used 150 mg daily for 30 days. There is no established requirement and no dose-finding consensus.
How much resveratrol is in red wine?
Only a few milligrams per litre. Reaching the low end of trial doses through wine would require drinking volumes that cause far more harm than any polyphenol could offset.
Does resveratrol actually extend lifespan?
That claim comes from yeast, worm and rodent work at high relative doses, and the sirtuin mechanism behind it is contested. No human trial has demonstrated a lifespan effect.
Why is resveratrol said to have poor bioavailability?
Human pharmacokinetic work shows it is absorbed but then almost entirely converted to sulfate and glucuronide metabolites, leaving very little unchanged resveratrol in circulation.
Are there side effects at high doses?
Yes. Gram-scale doses in trials have produced nausea, diarrhoea, abdominal discomfort and flatulence often enough to limit escalation.
Where does supplement resveratrol come from?
Most commercial resveratrol is extracted from Japanese knotweed rather than grapes, because the yield is far higher.
Can I take resveratrol with blood thinners?
Check with a prescriber first. Resveratrol inhibits platelet aggregation in laboratory studies and also inhibits enzymes that metabolise many medicines.
Keep reading
Sources
- Timmers S, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612–622.
- Walle T, et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32(12):1377–1382.
Track your dose in DoseRoutine
Log what you actually take, get reminders at the right time and check interactions against everything else in your stack.
Sign up free →